Effects of curcumin on crevicular levels of IL-1ß and CCL28 in experimental gingivitis.
Aust Dent J
; 60(3): 317-27, 2015 Sep.
Article
en En
| MEDLINE
| ID: mdl-26219195
ABSTRACT
BACKGROUND:
Curcumin has anti-inflammatory properties. The aim of this study was to compare interleukin-1ß (IL-1ß) and chemokine (C-C motif) ligand 28 (CCL28) levels following a topical application of curcumin (CRM), chlorhexidine (CHX) and chlorhexidine-metronidazole (CHX-MTZ) in an experimental gingivitis human model.METHODS:
Sixty systemically healthy selected subjects were randomly assigned to one of three topical antigingivitis gels. Each gel was applied twice daily for 10 minutes as the sole method of oral hygiene for 29 days on the test quadrant only. Modified gingival index (MGI), plaque index (PI), bleeding on probing (BOP) and probing depth (PD) were assessed at baseline, 29 days and 60 days. Estimation of IL-1ß and CCL28 levels in gingival crevicular fluid was done at baseline and at 29 days.RESULTS:
The increase of IL-1ß in the CRM (14.52 ± 16.6 pg/ml) and CHX-MTZ (31.63 ± 15.96) groups was significantly less than that of the CHX group (70.55 ± 38.81). Similar results were also observed for CCL28 (CRM 8.12 ± 8.78 pg/ml; CHX-MTZ 12.81 ± 18.68; CHX 41.15 ± 22.82). All groups had a significant increase in MGI, PI and BOP at 29 days.CONCLUSIONS:
The anti-inflammatory potential of topical curcumin was similar to CHX-MTZ but superior to CHX in affecting IL-1ß and CCL28 levels.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Métodos Terapéuticos y Terapias MTCI:
Terapias_biologicas
/
Aromoterapia
/
Plantas_medicinales
Asunto principal:
Líquido del Surco Gingival
/
Quimiocinas CC
/
Curcumina
/
Interleucina-1beta
/
Gingivitis
/
Antiinflamatorios
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Aust Dent J
Año:
2015
Tipo del documento:
Article
País de afiliación:
Malasia